Krishna M. Sundar

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 224 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Characteristics of carotid body chemosensitivity in NADPH oxidase-deficient mice

Liang He, J. Chen, B. Dinger et al. · American Journal of Physiology-Cell Physiology · 2002 · 84 citations

Life Sciences, Cell Biology, Molecular Biology +17

Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia

Radhika Gangaraju, Jihyun Song, Soo Jin Kim et al. · Blood Advances · 2020 · 77 citations · Full text

Medicine, Hematology, Molecular Genetics +17

Chronic cough and obstructive sleep apnea in a community-based pulmonary practice

Krishna M. Sundar, Sarah Daly, Michael J. Pearce et al. · Cough · 2010 · 69 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS)

Michelle Zeidler, Jennifer L. Martin, Eric C. Kleerup et al. · SLEEP · 2018 · 54 citations · Full text

Medicine, Internal Medicine, Pulmonary Function Testing +16